retatrutide phase 2 trial results weight loss approval: FDA status, clinical results, and when it could be available π¨Breaking: Retatrutide's first Phase 3
Description
Available at: The Online Clinic
WHAT are GLP-1s

Patient safety advice : If you experience persistent or severe abdominal pain (with or without vomiting), seek urgent medical attention and withhold further doses until assessed by a healthcare professional, as these symptoms may indicate pancreatitis

The hypoglycemic effect can reduce HbA1c by 2%

The new long-term weight loss medication helps people take control of their health by reducing appetite and cravings to avoid overeating or binge eating successfully
